Cargando…

Low Expression of KAT6B May Affect Prognosis in Hepatocellular Carcinoma

AIMS: Lysine acetyltransferase 6B (KAT6B), is a histone acetyltransferase implicated to have a role in tumor suppression. However, the relationship between KAT6B and hepatocellular carcinoma (HCC) is unclear. The purpose of this study was to detect the expression of KAT6B in HCC tissues and analyze...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Junjie, Wang, Hui-Ju, Mou, Xiao-Zhou, Zhang, Huanqing, Chen, YiZhen, Hu, Zhi-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411621/ https://www.ncbi.nlm.nih.gov/pubmed/34464167 http://dx.doi.org/10.1177/15330338211033063

Ejemplares similares

KAT6B May Be Applied as a Potential Therapeutic Target for Glioma
por: Liu, Yingzi, et al.
Publicado: (2022)

BRPF1-KAT6A/KAT6B Complex: Molecular Structure, Biological Function and Human Disease
por: Zu, Gaoyu, et al.
Publicado: (2022)

LbKAT3 may assist in mycorrhizal potassium uptake, and overexpression of LbKAT3 may promote potassium, phosphorus, and water transport from arbuscular mycorrhizal fungi to the host plant
por: Han, Xia, et al.
Publicado: (2023)

N4BP3 promotes angiogenesis in hepatocellular carcinoma by binding with KAT2B
por: Han, Hexu, et al.
Publicado: (2022)

The Kat in the HAT: The Histone Acetyl Transferase Kat6b (MYST4) Is Downregulated in Murine Macrophages in Response to LPS
por: Shukla, Smita, et al.
Publicado: (2018)

High expression of FOXO3 is associated with poor prognosis in patients with hepatocellular carcinoma
por: Song, Shu-Shu, et al.
Publicado: (2020)

Decreased DC-SIGNR expression in hepatocellular carcinoma predicts poor patient prognosis
por: Xia, Hai-Bing, et al.
Publicado: (2020)

Further delineation of the KAT6B molecular and phenotypic spectrum
por: Gannon, Tamsin, et al.
Publicado: (2015)

Sleep, Behavior, and Adaptive Function in KAT6A Syndrome
por: Smith, Clay, et al.
Publicado: (2021)

KATs in Cancer: Functions and Therapies
por: Farria, Aimee, et al.
Publicado: (2015)

Low expression of citron kinase is associated with poor patient outcomes in hepatocellular carcinoma
por: Zhang, Huan-Qing, et al.
Publicado: (2020)

Low-Shear Modeled Microgravity Enhances Salmonella Enterica Resistance to Hydrogen Peroxide Through a Mechanism Involving KatG and KatN
por: Pacello, Francesca, et al.
Publicado: (2012)

New KAT6 inhibitors induce senescence and arrest cancer growth
por: Huang, Fei
Publicado: (2018)

Acute Monoblastic Leukemia with Erythrophagocytosis and Absence of KAT6A Rearrangement
por: Sánchez, Carlos De Miguel, et al.
Publicado: (2020)

Alcohol dehydrogenase 4 is a TP53-associated gene signature for the prediction of prognosis in hepatocellular carcinoma
por: Zhang, Yuan, et al.
Publicado: (2022)

KAT6B Genetic Variant Identified in a Short Stature Chinese Infant: A Report of Physical Growth in Clinical Spectrum of KAT6B-Related Disorders
por: Zhu, Liuyan, et al.
Publicado: (2020)

Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma
por: Xia, Hai-Bing, et al.
Publicado: (2018)

Evaluation of nuclear PGAM2 value in hepatocellular carcinoma prognosis
por: Li, Yi-Ran, et al.
Publicado: (2021)

Food allergy in a child with de novo KAT6A mutation
por: Elenius, Varpu, et al.
Publicado: (2017)

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions
por: Zheng, Qiuxian, et al.
Publicado: (2021)

KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma
por: Saglam, Ozlen, et al.
Publicado: (2020)

MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway
por: Bai, Zhijie, et al.
Publicado: (2020)

m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma
por: Zou, Yan, et al.
Publicado: (2022)

Unique Features of Two Potassium Channels, OsKAT2 and OsKAT3, Expressed in Rice Guard Cells
por: Hwang, Hyunsik, et al.
Publicado: (2013)

Kat2a and Kat2b Acetyltransferase Activity Regulates Craniofacial Cartilage and Bone Differentiation in Zebrafish and Mice
por: Sen, Rwik, et al.
Publicado: (2018)

The single-nucleotide polymorphisms in CHD5 affect the prognosis of patients with hepatocellular carcinoma
por: Zhu, Xiao, et al.
Publicado: (2017)

Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation
por: Lin, Xia-Hui, et al.
Publicado: (2023)

Low ARID1A Expression is Associated with Poor Prognosis in Hepatocellular Carcinoma
por: Yim, Sun Young, et al.
Publicado: (2020)

The clinical spectrum of a nonsense mutation in KAT6A: a case report
por: Wang, Dongbo, et al.
Publicado: (2022)

Clinical features and underlying mechanisms of KAT6B disease in a Chinese boy
por: Sun, Xiaoang, et al.
Publicado: (2023)

KAT8 acetylation-controlled lipolysis affects the invasive and migratory potential of colorectal cancer cells
por: Qiu, Bingquan, et al.
Publicado: (2023)

AGO1 may influence the prognosis of hepatocellular carcinoma through TGF-β pathway
por: Wang, Miao, et al.
Publicado: (2018)

The MeerKAT Radio Telescope: First Science
por: Ratcliffe, Simon
Publicado: (2018)

Scale challenges of the MeerKAT Radio Telescope
por: Bennett, Thomas, et al.
Publicado: (2017)

MeerKAT Ceph updates from Mzanzi
por: Bennett, Thomas
Publicado: (2019)

A poor prognosis in human hepatocellular carcinoma is associated with low expression of DPP4
por: Yu, Hao, et al.
Publicado: (2020)

Implications of pseudogenes for the prognosis of hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2023)

ASEB: a web server for KAT-specific acetylation site prediction
por: Wang, Likun, et al.
Publicado: (2012)

Three brothers with a nonsense mutation in KAT6A caused by parental germline mosaicism
por: Satoh, Chisei, et al.
Publicado: (2017)

S125: NON-GENETIC RESISTANCE TO MENIN INHIBITION IN AML IS REVERSIBLE BY PERTURBATION OF KAT6A
por: Perner, Florian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a670j9hg6frca71p84d4md57h3